The T Cell Activator of Cell Killing ("TACK") IT ON" STUDY

计划入组 26 人 · 首次发布于 2025 年 2 月 12 日

Allogeneic Stem Cell Transplantation in Relapsed/Refractory T-, NK/T-cell Lymphomas

计划入组 34 人 · 首次发布于 2016 年 8 月 9 日

T-Regulatory Cell Kinetics, Stem Cell Transplantation, REGKINE

计划入组 26 人 · 首次发布于 2007 年 12 月 21 日

Tcrx T cell Therapy(Second Affiliated Hospital School Of Zhejiang University School Of Medicine)

TCR alpha/beta-T-cell CD19 and B-cell-depleted hematopoietic stem cell therapy

TCR T-cell therapy

T-Knife GmbH

Germany

PH & T SpA

Italy

Stem Cell Therapeutics Corp

Canada

Sartorius Stedim Biotech Partners with Nanotein Technologies to Enhance Cell Therapy Manufacturing with NanoSpark® Platform

Marengo and Ipsen Advance Second Novel T Cell Activator Drug Candidate for Cancer Immunotherapy

Soluble HER2 Drives CD8⁺ T-Cell Exhaustion and Limits Immunotherapy Response in HER2-Low Triple-Negative Breast Cancer